ABOUT AbClon
Overview
History
Business Portfolio
Scientific Advisory
Contact Us
ÀÎÀç»ó
º¹¸®ÈÄ»ý/ä¿ëÀýÂ÷
ÀÔ»çÁö¿ø
TECHNOLOGY
Biosynergy Antibody
YPLUS
AffiMab
THERAPEUTIC ANTIBODY
Pipeline
Antibody Drug Industry
ANTIBODY SERVICE
INVESTORS
ÁÖ°¡Á¤º¸
°ø½ÃÁ¤º¸
½ÃÀ庸°í¼
NOTICE
Notice/News
BIOSYNERGY ANTIBODY, YPLUS ¹×
AffiMab Ç÷§ÆûÀ» ¹ÙÅÁÀ¸·Î Çõ½Å Ç×ü
½Å¾àÀ» °³¹ßÇÕ´Ï´Ù.
½º¿þµ§ Ç×üÀü¹® ±×·ì°ú
Ç×¾ÏÁ¦ºÐ¾ß µî ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ
Ç×ü Ä¡·áÁ¦¸¦ °³¹ßÇϰí ÀÖ½À´Ï´Ù..
ADVANCED DRUG DISCOVERY SUPPORT
Ç׿øÁ¦ÀÛºÎÅÍ Ç×üÁ¦ÀÛ »Ó¸¸ ¾Æ´Ï¶ó
Ç×ü°ü·Ã Àü¹Ý¿¡ ÇÊ¿äÇÑ
¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.
¾ÛŬ·Ð, °íÇü¾Ï CAR-T ÆÄÀÌÇÁ¶óÀÎ È®..
¾ÛŬ·Ð, ÁÖ¿ä »óÀå Á¦¾à,¹ÙÀÌ¿À ±â¾÷ ..
¾ÛŬ·Ð, ¡®AT101¡¯·Î ±Û·Î¹ú CAR-T Ä¡..
±Û·Î¹ú ÇÁ·ÎÁ§Æ® HPA , Áö³ 20³â°£ ..